Literature DB >> 32620128

Serial ganglion impar blocks in a patient with nutcracker syndrome refractory to left renal vein transposition: a case report.

Shawn Banon1, Ioannis Skaribas2.   

Abstract

BACKGROUND: Nutcracker syndrome is a rare disorder caused by compression of the left renal vein, usually between the aorta and the superior mesenteric artery. It typically presents with left-sided abdominal pain and hematuria. Left renal vein transposition is the most commonly employed surgical technique to alleviate the compression. CASE
PRESENTATION: A 22-year-old Caucasian man with a known diagnosis of nutcracker syndrome had undergone left renal vein transposition 1 year before presentation without any subsequent pain relief. In addition, his surgery was complicated by massive blood loss and a 1-week-long stay in an intensive care unit (ICU); as such, he was not amenable to further surgical intervention or stenting to treat his underlying pathology. His symptoms included constant sharp left-sided flank, perineal, and testicular pain. A series of ganglion impar blocks were performed every 3-4 months over the course of 5 years with substantial pain relief achieved.
CONCLUSIONS: Our case report highlights a treatment option that has not yet been described for patients with pain secondary to nutcracker syndrome refractory to surgical intervention.

Entities:  

Keywords:  Ganglion impar block; Left renal vein transposition; Nutcracker syndrome

Year:  2020        PMID: 32620128      PMCID: PMC7333409          DOI: 10.1186/s13256-020-02398-6

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

Nutcracker syndrome is a disorder caused by compression of the left renal vein. The vein is usually compressed between the aorta and the superior mesenteric artery (SMA), known as “anterior nutcracker”; an anatomic variant of the left renal vein may course between the aorta and vertebra, where it can also be compressed, known as “posterior nutcracker” [1]. Proposed causes of compression include posterior renal ptosis, abnormally high course of the left renal vein, abnormal branching of the SMA from the aorta, pancreatic neoplasm, para-aortic lymphadenopathy, retroperitoneal tumor, and abdominal aortic aneurysm [2-6]. The syndrome is most commonly associated with left-sided flank pain, hematuria (either frank or microscopic), orthostatic proteinuria, and orthostatic intolerance [7-9]. Microscopic hematuria is four times more common than frank hematuria [10]. Hematuria occurs due to rupture of veins in the renal fornix secondary to renal vein hypertension [11]. Renal vein hypertension also causes inflammation, which is thought to cause the flank pain; alternatively, blood clots can form in the collecting system, causing flank pain as well [12, 13]. The flank pain may radiate to the buttocks, posteromedial thigh, or groin [13, 14]. In addition, the pain can be exacerbated by sitting, standing, or walking [15]. Symptoms range from asymptomatic microhematuria to severe and persistent pain. In females, it can alternatively present as pelvic congestion, characterized by dysmenorrhea; dyspareunia; postcoital ache; lower abdominal pain; dysuria; fatigue; and pelvic, vulvar, or thigh varices [16, 17]. In addition, males can present with lower limb varices and varicoceles [18]. Autonomic dysfunction, including hypotension, syncope, and tachycardia, may be seen, although this is a rare presentation [19]. The prevalence of the syndrome is unknown, but it may have a female predominance [20]. Patients may present anywhere from childhood to the seventh decade of life, although most present in their second or third decade, with a possible second peak in middle-aged women [21]. Typically, Doppler ultrasound is performed as an initial assessment, and the diagnosis is confirmed with renal angiography, computed tomographic angiogram, digital subtraction angiography, magnetic resonance imaging (MRI), or magnetic resonance angiography [13]. Chronology of treatment

Case presentation

A 22-year-old Caucasian man with a medical history of epilepsy, nephrolithiasis, and nutcracker syndrome presented with abdominal and perineal pain. The patient’s family history was negative for nutcracker syndrome and pelvic congestion syndrome. The pain was ongoing for approximately 3 years before the initial consultation, and a left renal vein transposition was undertaken 1 year before initial consultation, without any improvement in his symptoms (Fig. 1). The pain was located in the left flank as well as variably in the left lower quadrant and left lower back. The pain consistently radiated to the groin and perineum and variably radiated to the left posterior thigh. The patient described the pain as sharp, shooting, and piercing. His pain was constant, with a baseline intensity of 6/10 on the visual analogue scale. His pain improved with medications, including gabapentin and hydrocodone-acetaminophen, restricting movement, and lying flat; it worsened with movement and sitting upright or standing. Associated signs included a varicocele, which had been repaired 6 years before initial consultation, and associated symptoms included infrequent nausea and vomiting. The patient’s vital signs were within normal limits. His physical examination revealed tenderness to palpation over the left flank without rebound tenderness or guarding. His laboratory test values were normal, except for microscopic hematuria on urinalysis. Due to continued flank pain at 6 months postoperatively, a repeat renal angiogram/venogram was obtained, which showed that although the left renal vein was successfully transposed, the left renal vein remained compressed with continued mild reflux into the left adrenal and left lumbar veins. Because our patient’s pain variably radiated into his posterior thigh, MRI of the lumbar spine was conducted, which showed mild bilateral L4 and L5 foraminal stenosis and mild disc bulge with mild mass effect on the left L5 nerve root. Even so, the results of straight leg raise and reverse straight leg raise tests were negative. In addition, the results of electromyography of the sciatic nerve and its branches were normal.
Fig. 1

Chronology of treatment

The patient underwent a diagnostic celiac plexus block with 70% improvement in his symptoms for 6 days, indicating a high likelihood of visceral origin of his pain. A celiac plexus neurolytic block was subsequently performed but relieved only 60% of his pain for 2 months. He was administered an injection of 5 ml of 0.25% bupivacaine followed by 15 ml of 98% dehydrated alcohol using the central technique. Although his flank pain was almost entirely relieved, his perineal and testicular pain, which was far more bothersome, persisted. As such, a ganglion impar block was undertaken, which significantly improved his pain (80% for 3 months). The block included 15 ml of 0.25% bupivacaine with 15 mg of dexamethasone. As a result, the patient underwent serial ganglion impar blocks over the course of 5 years, which significantly improved his symptoms (70–100%, lasting for 3–4 months). Some residual mild left flank pain persisted at times. Ganglion impar neurolysis was proposed; however, the patient declined for two reasons. Primarily, he was fearful of the possibility of perineal and testicular dysesthesias and hyperesthesias. Secondarily, because pain relief from neurolysis generally lasts no more than 6 months, he did not think the benefits outweighed the risks, considering that he was already benefiting from long-lasting pain relief from his current intervention. Although ganglion impar blocks were relieving his symptoms well, the patient wanted to explore more permanent options after approximately 2 years of consultation. For this reason, an intrathecal morphine trial was undertaken, but he was dissatisfied because of excessive pruritus and constipation and only a 60% reduction in pain. Later, a dorsal root ganglion trial was proposed; however, the patient had hesitation concerning permanent implantation of a device at that time. No adverse or unanticipated events have occurred as a result of his ganglion impar blocks.

Discussion

Treatment of nutcracker syndrome varies, depending on the patient’s age and severity of symptoms. Pediatric patients have a higher rate of spontaneous remission, and, as such, patients younger than 18 are usually surveilled for 2 years versus 6 months in adults. Seventy-five percent of pediatric patients will have complete resolution of their hematuria in this time period [22]. This is thought to be secondary to an increase in intra-abdominal fibrous tissue at the origin of the SMA and an increase in retroperitoneal adipose tissue, which may increase the SMA–aorta angle and relieve tension on the left renal vein; the development of venous collaterals may play a role as well [12, 23, 24]. Surgeries are reserved for patients with severe and persistent symptoms in whom conservative treatment has failed. Surgical therapies include medial nephropexy, left renal vein bypass, left renal vein transposition, SMA transposition, renal autotransplant, gonadocaval bypass, renal to inferior vena cava inferior vena cava (IVC) shunt, and nephrectomy [1–3, 9, 15, 21, 24, 25]. In addition, the left renal vein can be stented endovascularly [26]. Left renal vein transposition is the most commonly employed surgical technique and is currently considered the gold standard on the basis of good outcomes and relatively low complication rates [23]. It involves excision of the vessel from the inferior vena cava (IVC), repair of the vena caval defect, and reanastomosis more distally along the inferior vena cava (IVC). In a 2002 study, seven of eight patients who received left renal vein transposition had resolution of their symptoms in from 41 to 136 months, with one patient experiencing persistent hematuria. Postoperative complications included deep vein thrombosis, retroperitoneal hematoma, and mechanical ileus [27]. Similarly, a 2009 study showed that nine of ten patients who underwent the surgery had improvement or resolution of their flank pain at 11 to 149 months, whereas hematuria resolved in all patients. Complications included chylous ascites, retroperitoneal hematoma, and left renal vein thrombosis [28]. Another 2009 study showed that six of seven patients who underwent the surgery had resolution of their symptoms in from 14 to 122 months, with one patient experiencing persistent pain; no postoperative complications were noted [29]. Our patient was in the minority of patients who did not experience pain relief from the surgery. In addition, because his surgery was complicated by massive blood loss and a 1-week-long stay in an intensive care unit (ICU), he was hesitant to undergo another surgery or stenting and opted to have his symptoms treated by a pain management physician instead. The decision to undergo ganglion impar blocks rather than repeat celiac plexus neurolysis stemmed from our patient’s response to the interventions. The majority of his pain was in the testicular and perineal area, with only a minority in the left flank. As a result, our patient experienced more pain relief with ganglion impar blocks. However, the minority of pain not covered was usually in his left flank as a result. The patient was aware that risks of repeated steroid injections include weight gain, insulin resistance, and increased blood pressure; however, he felt that the benefits outweighed the risks. In addition, the patient was aware that his pathology persisted despite his pain relief. Overall, the patient has been satisfied with his results thus far.

Conclusion

We report the successful treatment of abdominal, perineal, and testicular pain in a 22-year-old man with nutcracker syndrome. Our case report highlights a treatment option that has not yet been described for patients with pain secondary to nutcracker syndrome refractory to surgical intervention.
  28 in total

1.  Orthostatic proteinuria as a result of venous compression (nutcracker phenomenon)--a hypothesis testable with modern imaging techniques.

Authors:  M Ekim; S A Bakkaloglu; N Tümer; U Sanlidilek; M Salih
Journal:  Nephrol Dial Transplant       Date:  1999-04       Impact factor: 5.992

Review 2.  Mesoaortic compression of the left renal vein (nutcracker syndrome): case reports and review of the literature.

Authors:  Udo Rudloff; Raymond J Holmes; Jeffrey T Prem; Glenn R Faust; Robert Moldwin; David Siegel
Journal:  Ann Vasc Surg       Date:  2006-01       Impact factor: 1.466

Review 3.  Nutcracker syndrome--how well do we know it?

Authors:  Yangyan He; Ziheng Wu; Shanwen Chen; Lu Tian; Donglin Li; Ming Li; Wei Jin; Hongkun Zhang
Journal:  Urology       Date:  2013-10-18       Impact factor: 2.649

4.  Posterior nutcracker syndrome.

Authors:  Nedaa Skeik; Peter Gloviczki; Thanila A Macedo
Journal:  Vasc Endovascular Surg       Date:  2011-09-02       Impact factor: 1.089

5.  Endovascular stenting for the nutcracker phenomenon.

Authors:  R Chiesa; A Anzuini; E M Marone; C Briguori; M R Moura; G Melissano; A Colombo; S Rosanio
Journal:  J Endovasc Ther       Date:  2001-12       Impact factor: 3.487

Review 6.  Nutcracker syndrome: when should it be treated and how?

Authors:  Matthew T Menard
Journal:  Perspect Vasc Surg Endovasc Ther       Date:  2009-08-23

7.  The nutcracker syndrome: an uncommon cause of haematuria.

Authors:  K R Shaper; J E Jackson; G Williams
Journal:  Br J Urol       Date:  1994-08

8.  The nutcracker syndrome: new aspects of pathophysiology, diagnosis and treatment.

Authors:  M Hohenfellner; F Steinbach; D Schultz-Lampel; W Schantzen; K Walter; B M Cramer; J W Thüroff; R Hohenfellner
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

9.  Spontaneous remission of persistent severe hematuria in an adolescent with nutcracker syndrome: seven years' observation.

Authors:  Hiroshi Tanaka; Shinobu Waga
Journal:  Clin Exp Nephrol       Date:  2004-03       Impact factor: 2.801

10.  Effect of renal Doppler ultrasound on the detection of nutcracker syndrome in children with hematuria.

Authors:  Jae Il Shin; Jee Min Park; Jae Seung Lee; Myung Joon Kim
Journal:  Eur J Pediatr       Date:  2006-10-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.